Caribou Biosciences, Inc. announced a strategic shift focusing on its lead oncology programs, CB-010 and CB-011, involving workforce and cost reductions aimed at extending its cash runway into the ...

BOSTON, July 25, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and ...

SOUTH PLAINFIELD, N.J., Sept. 28, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (PTCT) announced today further strategic prioritization and associated workforce reduction. The portfolio prioritization ...

The human genome contains approximately 1,600 types of transcription factors responsible for regulating gene activity across ...

While Dow has a strong legacy of water stewardship, returning over 96% of withdrawn water sustainably, growing demand and ...

-- CB-010 ANTLER 2L LBCL Phase 1 dataset expected to include at least six months of follow up on the majority of patients; ongoing interactions with FDA on potential pivotal trial design -- -- CB-011 ...

Strategy fails when it ignores human energy. Learn how leaders can design strategy around motivation, focus, and recovery to ...

Douglas, a technical analyst, came to me having gained extensive experience within a niche market, seeking to transition into an analyst or market research role. He had developed a two-page resume ...

Researchers at University of Tsukuba have comprehensively analyzed genomic binding data of transcription factors (proteins that regulate gene expression) in humans, revealing a substantial amount of ...